Skip to main content
. 2021 Nov 9;13(11):e19400. doi: 10.7759/cureus.19400

Figure 3. Biomarker analysis by liquid biopsy.

Figure 3

Biomarker analysis of BRAF-V600E in CSF (upper panel) and plasma (lower panel): cfDNA separated on the Agilent 2100 Bioanalyzers with an HS DNA chip. Fragment length distribution shows mono-, di-, and tri-nucleosomal peaks, as well as high molecular weight DNA.

CSF, cerebrospinal fluid; cfDNA, cell-free DNA; HS, high sensitivity